Marco Galluzzo
69PUBLICATIONS
130CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (69)
Sort by Publication Date:
|Mar 13, 2026
AVT04, a Biosimilar to Reference Product Ustekinumab, for the Treatment of Plaque Psoriasis: Insights from a Real-World Experience up to 28 Weeks.Edoardo Mortato, Marina Talamonti, Lorenzo Savastano
|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.Emanuele Trovato, Claudio Bonifati, Simone Ribero
|Jan 28, 2026
Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis.Edoardo Mortato, Lorenzo Marcelli, Agostino Panichelli
|Nov 03, 2025
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors.Niccolò Gori, Lucia Di Nardo, Elena Ippoliti
|Sep 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study.Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli
Pageof 12
Frequent Collaborators
37 joint publications
Marina Talamonti
18 joint publications
Luca Bianchi
9 joint publications
Andrea Chiricozzi
8 joint publications
Giacomo Caldarola
8 joint publications
Elena Campione
7 joint publications
Nicoletta Bernardini
6 joint publications
Cosimo Di Raimondo
5 joint publications
Lorenzo Tofani
5 joint publications
Clara De Simone
5 joint publications
Claudia Paganini
